Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-19

Clinical Trial Update: Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated how quickly patients with maxillary sinusitis experienced symptom relief and how effectively the infecting bacteria were eradicated wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Maxillary Sinusitis | Phase 4 | Status: COMPLETED